Tobin Scientific Closes $65M Investment to Accelerate Growth Across Life Sciences Infrastructure
Tobin Scientific, a leading provider of cGMP storage and biorepository services, has secured a $65M minority growth equity investment led by Denali Growth Partners and Truck 9 Partners, along with financing from Eastern Bank. The company, which operates over 365,000 square feet of cold chain and ambient warehouse space, will use the funding to expand its cGMP-compliant storage and logistics capacity, broaden its geographic presence in key pharmaceutical hubs, and pursue M&A opportunities. The executive management team remains unchanged, with no change in control.
The company specializes in cold chain transport, compliant storage solutions, and end-to-end project execution for laboratories, manufacturing sites, and biorepositories across the U.S. Stifel Financial Corp. acted as the exclusive financial advisor for the transaction.
Tobin Scientific, un fornitore leader di servizi di stoccaggio cGMP e biorepository, ha ottenuto un investimento di crescita minoritario di 65 milioni di dollari guidato da Denali Growth Partners e Truck 9 Partners, insieme a un finanziamento da Eastern Bank. L'azienda, che gestisce oltre 365.000 piedi quadrati di spazi per magazzini a catena del freddo e a temperatura ambiente, utilizzerà i fondi per espandere la capacità di stoccaggio e logistica conforme a cGMP, ampliare la propria presenza geografica in hub farmaceutici chiave e perseguire opportunità di fusioni e acquisizioni. Il team di gestione esecutiva rimane invariato, senza cambiamenti nel controllo.
L'azienda è specializzata nel trasporto a catena del freddo, soluzioni di stoccaggio conformi e nell'esecuzione completa di progetti per laboratori, siti produttivi e biorepository negli Stati Uniti. Stifel Financial Corp. ha agito come consulente finanziario esclusivo per la transazione.
Tobin Scientific, un proveedor líder de servicios de almacenamiento cGMP y biorepositorios, ha asegurado una inversión minoritaria de crecimiento de 65 millones de dólares liderada por Denali Growth Partners y Truck 9 Partners, junto con financiamiento de Eastern Bank. La compañía, que opera más de 365,000 pies cuadrados de espacio de almacén en cadena de frío y ambiente, utilizará los fondos para ampliar su capacidad de almacenamiento y logística conforme a cGMP, expandir su presencia geográfica en centros farmacéuticos clave y buscar oportunidades de fusiones y adquisiciones. El equipo ejecutivo permanece sin cambios, sin alteraciones en el control.
La empresa se especializa en transporte en cadena de frío, soluciones de almacenamiento conformes y ejecución integral de proyectos para laboratorios, sitios de fabricación y biorepositorios en todo Estados Unidos. Stifel Financial Corp. actuó como asesor financiero exclusivo para la transacción.
Tobin Scientific은 cGMP 저장 및 바이오리포지토리 서비스 분야의 선도 업체로, Denali Growth Partners와 Truck 9 Partners가 주도하고 Eastern Bank가 금융 지원한 6500만 달러 규모의 소수 지분 성장 투자를 확보했습니다. 이 회사는 365,000평방피트 이상의 콜드체인 및 상온 창고 공간을 운영하며, 이번 자금을 통해 cGMP 준수 저장 및 물류 역량을 확장하고 주요 제약 허브에서 지리적 입지를 넓히며 M&A 기회를 모색할 계획입니다. 경영진은 변동 없이 기존 체제를 유지합니다.
이 회사는 미국 전역의 실험실, 제조 현장 및 바이오리포지토리를 위한 콜드체인 운송, 규정 준수 저장 솔루션, 그리고 프로젝트 전반에 걸친 실행을 전문으로 합니다. Stifel Financial Corp.가 이번 거래의 독점 재무 자문을 맡았습니다.
Tobin Scientific, un fournisseur de premier plan en services de stockage cGMP et de biobanques, a obtenu un investissement minoritaire de croissance de 65 millions de dollars mené par Denali Growth Partners et Truck 9 Partners, avec un financement d'Eastern Bank. L'entreprise, qui exploite plus de 365 000 pieds carrés d'espaces d'entrepôt en chaîne du froid et à température ambiante, utilisera ces fonds pour étendre sa capacité de stockage et logistique conforme aux cGMP, élargir sa présence géographique dans des pôles pharmaceutiques clés et poursuivre des opportunités de fusions et acquisitions. L'équipe de direction reste inchangée, sans changement de contrôle.
L'entreprise est spécialisée dans le transport en chaîne du froid, les solutions de stockage conformes et l'exécution complète de projets pour des laboratoires, sites de production et biobanques à travers les États-Unis. Stifel Financial Corp. a agi en tant que conseiller financier exclusif pour cette transaction.
Tobin Scientific, ein führender Anbieter von cGMP-konformen Lager- und Biorepositorium-Dienstleistungen, hat eine 65-Millionen-Dollar Minderheitsbeteiligung erhalten, die von Denali Growth Partners und Truck 9 Partners angeführt wird, sowie eine Finanzierung von Eastern Bank. Das Unternehmen betreibt über 365.000 Quadratfuß an Kühlketten- und Lagerflächen bei Umgebungstemperatur und wird die Mittel nutzen, um seine cGMP-konforme Lager- und Logistikkapazität zu erweitern, seine geografische Präsenz in wichtigen pharmazeutischen Zentren auszubauen und M&A-Möglichkeiten zu verfolgen. Das Führungsteam bleibt unverändert, es gibt keine Kontrolländerung.
Das Unternehmen spezialisiert sich auf den Transport in der Kühlkette, konforme Lagerlösungen und die vollständige Projektdurchführung für Labore, Produktionsstätten und Biorepositorien in den USA. Stifel Financial Corp. war exklusiver Finanzberater bei der Transaktion.
- Secured significant $65M investment for expansion and growth
- Maintains extensive infrastructure with 365,000 square feet of warehouse space
- Strategic expansion planned in key pharmaceutical hubs
- Management team stability with no change in control
- Additional M&A opportunities identified for growth
- Terms of the transaction not disclosed
- Minority stake sale could limit full strategic control
Insights
Tobin Scientific's $65M capital raise enables strategic expansion in specialized life sciences infrastructure without diluting management control.
The
This funding approach demonstrates sophisticated capital strategy, providing Tobin Scientific with substantial growth resources without sacrificing strategic direction. The company has outlined three specific deployment targets for this capital: expanding cGMP-compliant storage capacity, broadening geographic presence in key pharmaceutical hubs, and pursuing targeted M&A opportunities across the life sciences supply chain.
Tobin Scientific's current infrastructure footprint of 365,000 square feet of temperature-controlled and ambient warehouse space positions them as a meaningful player in the pharmaceutical services sector. Their focus on "white-glove" specialized logistics for highly regulated pharmaceutical products represents a premium service positioning in a niche but critical market segment.
The involvement of multiple capital providers signals broad institutional confidence in Tobin Scientific's business model and growth trajectory. The company's emphasis on supporting clients "at every stage of the R&D and manufacturing lifecycle from discovery through commercialization" indicates a comprehensive service approach that can capture pharmaceutical client relationships across multiple value chain points.
While specific financial metrics and transaction terms remain undisclosed, this capital raise provides Tobin Scientific with significant resources to execute their expansion strategy in the specialized pharmaceutical infrastructure sector.
Tobin Scientific is widely recognized for its white-glove approach to biopharma logistics, including cold chain transport, compliant storage solutions, and end-to-end project execution for laboratories, manufacturing sites, and biorepositories across the
"This capital raise marks a major milestone for our team and organization," said Brian Tobin, CEO of Tobin Scientific. "We're building critical infrastructure to support our clients at every stage of the R&D and manufacturing lifecycle from discovery through commercialization. Our partners share that vision, and this investment enables us to continue scaling with confidence and purpose. This investment is a testament to the dedication and expertise of our growing team and their commitment to the highest standards of service."
"We are pleased to provide this credit facility to support Tobin Scientific's strategic growth initiatives," said Gregory Buscone, Executive Vice President, Chief Commercial Banking Officer at Eastern Bank. "Tobin Scientific's commitment to expanding critical infrastructure and specialized pharma services plays a vital role. We are proud to help enable their vision of meeting the evolving needs of their customers in the
"We are proud to invest in Tobin Scientific's continued growth. The company's strong track record and strategic vision highlight its commitment to becoming the leading vertically integrated services provider to the pharmaceutical industry, with innovative, forward-thinking solutions," said Jesse Lane, the Founder and Managing Partner of Denali Growth Partners. "Tobin Scientific's ability to drive sustained revenue growth is a direct result of its unwavering focus on meeting customer needs with consistency, reliability, and white-glove service," added Alec Douglas of Denali Growth Partners.
Tom Babich, Managing Director of Stifel Financial Corp., served as the exclusive financial advisor to Tobin Scientific. Terms of the transaction were not disclosed.
About Tobin Scientific
Tobin is a trusted leader in biopharma cold chain, ambient storage, and transport & logistics services. With a national footprint and decades of experience, Tobin Scientific offers a wide range of services, including laboratory relocation, cold chain transport, and cGMP warehousing. The company is dedicated to ensuring the safe and reliable transport and storage of temperature-sensitive products. Visit TobinScientific.com for more information.
About Denali Growth Partners
Denali Growth Partners ("DGP") is a
About Eastern Bank
Founded in 1818, Eastern Bank is
About Stifel Financial Corp.
Stifel Financial Corp. (NYSE: SF) is a financial services holding company headquartered in
About Truck 9 Partners
Truck 9 Partners, based in
View original content to download multimedia:https://www.prnewswire.com/news-releases/tobin-scientific-closes-65m-investment-to-accelerate-growth-across-life-sciences-infrastructure-302448652.html
SOURCE Tobin Scientific
FAQ
What is the size of Tobin Scientific's recent investment round in 2025?
How much warehouse space does Tobin Scientific currently operate?
What will Tobin Scientific use the $65M investment for?
Who led the investment round in Tobin Scientific?
Will there be any changes to Tobin Scientific's management team after the investment?
